Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma
Objectives Combination of Breast Cancer 1 protein-associated protein 1 (BAP1) and methylthioadenosine phosphorylase (MTAP) in the peritoneal mesothelioma (PeM) has yet to be explored. We aim to assess the diagnostic value of combined BAP1 and MTAP to distinguish biphasic mesothelioma (BM) from epith...
Main Authors: | Yue Chen, Xuemei Du, Ying Gao, Heliang Wu, Hongyu Zhao, Yandong Su |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-12-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/10732748231220805 |
Similar Items
-
Methylthioadenosine phosphorylase deficiency in tumors: A compelling therapeutic target
by: Na Fan, et al.
Published: (2023-04-01) -
Genomic landscape of non‐small‐cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiency
by: Prashanth Ashok Kumar, et al.
Published: (2023-01-01) -
Loss of 5′-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness
by: Weder Pereira de Menezes, et al.
Published: (2020-02-01) -
Methylthioadenosine suppresses Salmonella virulence
by: Bourgeois, J, et al.
Published: (2018) -
Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis
by: Wang, L, et al.
Published: (2017)